Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Imperial College London · Royal Brompton & Harefield NHS Foundation Trust · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,115
total citations
- FWCI
- 114.16
- Percentile
- 100%
- References
- 115
Citations per year
Authors
3- PMPeter M. George
Imperial College London, Royal Brompton & Harefield NHS Foundation Trust
- AUAthol U. Wells
Royal Brompton & Harefield NHS Foundation Trust, Imperial College London
- GJGísli JenkinsCorresponding
Nottingham Biomedical Research Centre, University of Nottingham, National Institute for Health Research
Topics & keywords
Topics
Keywords
- Medicine
- Pulmonary fibrosis
- Pneumonia
- Internal medicine
- Idiopathic pulmonary fibrosis
- Pandemic
- Intensive care medicine
- Fibrosis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.